Back to Search
DR. MICHELE DEGREGORIO M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1306808175IndividualAccepts Medicare
Specialties, Licenses & Credentials
Interventional Cardiology Physician
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
165662(MT)4301070779(MI)
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
4301070779(MI)
Education
OTHER
Class of 1988
Research & Publications (19)
Pharmacologic effects of ospemifene in rhesus macaques: a pilot study.
PMID 18346046·Basic Clin Pharmacol Toxicol·2008
7-preclinical
Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations.
PMID 16047147·Cancer Chemother Pharmacol·2006
4-observational
Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women.
PMID 16816926·J Bone Miner Metab·2006
3-trial
Ineffectiveness of American ginseng in the prevention of dimethylbenzanthracene-induced mammary tumors in mice.
PMID 17476970·Oncol Res·2006
4-observational
Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.
PMID 16280035·Breast Cancer Res·2005
7-preclinical
Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice.
PMID 16153821·J Steroid Biochem Mol Biol·2005
4-observational
"I'm going to die of something anyway": women's perceptions of tamoxifen for breast cancer risk reduction.
PMID 16108294·Ethn Dis·2005
3-trial
Development of a multicenter peripheral arterial interventional database: the PVD-QI2.
PMID 15976781·Am Heart J·2005
8-other
Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract, and tolerability in postmenopausal women.
PMID 15772568·Menopause·2005
3-trial
Phase I trial of high-dose tamoxifen in combination with cisplatin in patients with lung cancer and other advanced malignancies.
PMID 12643003·Cancer Invest·2003
3-trial
Pharmacokinetics of selective estrogen receptor modulators.
PMID 12648026·Clin Pharmacokinet·2003
6-review
Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women.
PMID 12443837·Maturitas·2002
3-trial
High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma.
PMID 11505406·Cancer·2001
3-trial
In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer.
PMID 11457665·J Steroid Biochem Mol Biol·2001
7-preclinical
Pharmacokinetics of (deaminohydroxy)toremifene in humans: a new, selective estrogen-receptor modulator.
PMID 11049009·Eur J Clin Pharmacol·2000
3-trial
Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
PMID 10845810·Breast Cancer Res Treat·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via CARDIOLOGY AND VASCULAR ASSOCIATES PC · 2 locations total
- Address
- 42557 WOODWARD AVE, SUITE 200
BLOOMFIELD HILLS, MI 48304 - Phone
- (248) 333-1170
Quick Facts
- NPI
- 1306808175
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 38
- Publications
- 19
Are you this provider?
Claim Your Profile